Skip to content
BioLab
Back to Labs
BioLab · research library

Literature Workspace

Explore evidence. Connect research.

References, not copies: every entry links to its original source and keeps where its metadata came from. Reading states organise the library; they are not a judgement of scientific quality.

References
21
Collections
4
Sources
3

1 reference

Research article 2020 Reviewed MVA Hackathon 2026 — BUB1B

Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1–2 trial

Kara L Davis, Elizabeth Fox, Melinda S Merchant and 8 more The Lancet Oncology

Evidence snapshot note: Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412). Model: Pediatric and young-adult relapsed/refractory malignancies; phase 1-2.. Where: Abstract, findings and interpretation; no figure-level extraction. · cited by MVA-IMMUNE-011

  • PD-1 inhibitors
  • childhood cancer
  • lymphoma
  • rhabdomyosarcoma

Researcher sign-in

Sign in with your Stackfire account to save references, build collections and tag the library. Reading is open to everyone.

Add reference

Paste a DOI, PMID, PMCID, NCT number or a URL that carries one. Metadata is fetched from the public sources and shown before anything is saved.

New collection

Edit

KBot · Research guide

Prewritten answers · Evidence linked

KBot

Hello, I am KBot, the BioLab research guide. I can explain the research cases, the Literature Workspace, the Evidence Graph and the analysis tools, and where each one stops. Choose a topic below. These are prewritten explanations, not a live AI consultation.

Research information, not individual medical advice. No messages are sent or saved.